Related Experiment Videos

Increased plasma fibronectin concentration in diabetic patients with microalbuminuria

L A De Giorgio1, G Bartolomei, A Gironi

  • 1Outpatient Clinic for Diabetes, Pistoia, Italy.

Diabetes Care
|July 1, 1988
PubMed

Insights

Increased plasma fibronectin (PF) levels are linked to microalbuminuria in diabetes. This finding suggests PF may serve as an early marker for diabetic nephropathy, independent of other factors.

Area of Science:

  • Endocrinology and Metabolism
  • Nephrology
  • Vascular Biology

Background:

  • Plasma fibronectin (PF) elevations are noted in diabetic patients with retinopathy and overt nephropathy.
  • Microalbuminuria signifies early kidney damage in diabetes.

Purpose of the Study:

  • To determine if microalbuminuria correlates with increased plasma fibronectin concentrations in diabetic patients.
  • To investigate PF as a potential early indicator of diabetic nephropathy.

Main Methods:

  • Compared PF levels in diabetic patients with and without microalbuminuria against control subjects.
  • Analyzed PF correlation with albumin excretion rate (AER) and other clinical variables.
  • Utilized covariance analysis to assess independence from age, duration, sex, blood pressure, and glycemic control (HbA1).

Main Results:

  • Mean PF was significantly higher in diabetic patients with microalbuminuria compared to those without and controls (P < .05).
  • PF elevation associated with microalbuminuria was independent of retinopathy.
  • A significant positive correlation was found between PF and AER (r = .33, P = .003), persisting after adjusting for covariates.

Conclusions:

  • Increased plasma fibronectin is associated with microalbuminuria in diabetes, independent of other clinical factors.
  • PF may represent a valuable biomarker for detecting early-stage diabetic nephropathy.
  • Further research is needed to fully elucidate the role of PF in diabetic kidney disease progression.

Related Concept Videos